China First Capital Group Limited (1269.HK)
HKD 0.05
(-5.45%)
HKD 0.05
(-5.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.83 Billion | 1.19 Billion | 1.09 Billion | 1.02 Billion | 1.43 Billion | 1.81 Billion |
| Cost of Revenue | 1.43 Billion | 997.8 Million | 923.53 Million | 854.42 Million | 1.06 Billion | 1.38 Billion |
| Gross Profit | 401.12 Million | 202.11 Million | 170.29 Million | 175.54 Million | 370.57 Million | 425.71 Million |
| Operating Expenses | 517.23 Million | 440.45 Million | 886.79 Million | 442.18 Million | 2.45 Billion | 1.63 Billion |
| Selling, General and Administrative Expenses | 216.81 Million | 208.31 Million | 353.67 Million | 342.85 Million | 666.01 Million | 495.94 Million |
| Research and Development Expenses | 104.34 Million | 64.5 Million | 59.9 Million | 53.99 Million | 51.32 Million | 48.93 Million |
| Other Expenses | 196.07 Million | 19.99 Million | -16.2 Million | 1.42 Million | -117.99 Million | 3.15 Million |
| Cost and Expenses | 1.94 Billion | 1.43 Billion | 1.81 Billion | 1.29 Billion | 3.51 Billion | 3.01 Billion |
| Operating Income | -116.11 Million | -32.04 Million | -221.81 Million | -199.37 Million | -290.62 Million | -95.13 Million |
| Interest Expense | 161.07 Million | 198.27 Million | 197.44 Million | 206.82 Million | 285.97 Million | 245.81 Million |
| Income Tax Expense | -239 Thousand | 333 Thousand | 1.71 Million | 6.09 Million | 1.49 Million | 6.89 Million |
| Earnings before Tax | -366.22 Million | -419.9 Million | -887.3 Million | -453 Million | -2.25 Billion | -1.34 Billion |
| Net Income | -347.17 Million | -420.73 Million | -798.91 Million | -397.57 Million | -2.18 Billion | -1.38 Billion |
| Earnings Per Share Basic | -0.19 | -0.28 | -0.73 | -0.40 | -2.20 | -1.40 |
| Earnings Per Share Diluted | -0.19 | -0.28 | -0.73 | -0.40 | -2.18 | -1.40 |
| Weighted Average Shares Outstanding | 1.79 Billion | 1.5 Billion | 1.09 Billion | 1 Billion | 994.46 Million | 983.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.79 Billion | 1.52 Billion | 1.09 Billion | 1 Billion | 1 Billion | 983.95 Million |
| Gross Margin | 0.22 | 0.17 | 0.16 | 0.17 | 0.26 | 0.24 |
| EBIT Margin | -0.08 | 0.02 | -0.15 | -0.09 | -0.11 | 0.00 |
| Profit Margin | -0.19 | -0.35 | -0.73 | -0.39 | -1.52 | -0.76 |
| EBITDA | -141.06 Million | -152.29 Million | -160.45 Million | -115.15 Million | -156.46 Million | -998.03 Million |
| Earnings Before Tax Margin | -0.06 | -0.03 | -0.20 | -0.19 | -0.20 | -0.05 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 877.59 Million | 1.1 Billion | 1.83 Billion | 728.85 Million | 664.99 Million | 1.19 Billion |
| Cost of Revenue | 775.75 Million | 799.08 Million | 1.43 Billion | 633.5 Million | 532.12 Million | 997.8 Million |
| Gross Profit | 101.84 Million | 305.77 Million | 401.12 Million | 95.35 Million | 132.86 Million | 202.11 Million |
| Operating Expenses | 238.28 Million | 278.04 Million | 539.79 Million | 244.56 Million | 128.71 Million | 440.45 Million |
| Selling, General and Administrative Expenses | 155.96 Million | 322.06 Million | - | 142.22 Million | 105.12 Million | - |
| Research and Development Expenses | 35.41 Million | 67.73 Million | - | 36.61 Million | 39.46 Million | - |
| Other Expenses | 46.9 Million | -111.74 Million | 25.34 Million | - | - | 19.99 Million |
| Cost and Expenses | 1.01 Billion | 1.07 Billion | 1.97 Billion | 878.07 Million | 660.84 Million | 1.43 Billion |
| Operating Income | -136.44 Million | 27.72 Million | -116.11 Million | -59.66 Million | 17.32 Million | -32.04 Million |
| Interest Expense | - | - | 161.07 Million | - | - | 198.27 Million |
| Income Tax Expense | 876 Thousand | 876 Thousand | -239 Thousand | 637 Thousand | 208 Thousand | 333 Thousand |
| Earnings before Tax | -246.51 Million | -151.04 Million | -366.22 Million | -215.18 Million | -96.89 Million | -419.9 Million |
| Net Income | -222.02 Million | -152.95 Million | -347.17 Million | -194.22 Million | -124.12 Million | -420.73 Million |
| Earnings Per Share Basic | -0.12 | -0.08 | - | -0.11 | -0.08 | - |
| Earnings Per Share Diluted | -0.12 | -0.08 | - | -0.11 | -0.07 | - |
| Weighted Average Shares Outstanding | 1.84 Billion | 1.84 Billion | 1.79 Billion | 1.73 Billion | 1.62 Billion | 1.5 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.84 Billion | 1.84 Billion | 1.79 Billion | 1.73 Billion | 1.7 Billion | 1.52 Billion |
| Gross Margin | 0.12 | 0.28 | 0.22 | 0.13 | 0.20 | 0.17 |
| EBIT Margin | -0.06 | -0.03 | - | -0.04 | 0.08 | - |
| Profit Margin | -0.25 | -0.14 | -0.19 | -0.27 | -0.19 | -0.35 |
| EBITDA | -51.57 Million | -30.87 Million | - | -31.61 Million | 50.78 Million | - |
| Earnings Before Tax Margin | -0.16 | 0.03 | -0.06 | -0.08 | 0.03 | -0.03 |
6886
PNCINFRA
WINMED
603050
IPCM
MDM